← ESTA
ESTA— ESTABLISHMENT LABS HOLDINGS INC.
Health CareOrthopedic, Prosthetic & Surgical Appliances & Supplies
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $211.1M+27.1% | $166.0M+0.5% | $165.2M+2.1% | $161.7M+27.6% | $126.7M+49.6% | $84.7M-5.5% | $89.6M |
| Cost of revenue | $64.8M+14.6% | $56.5M-2.9% | $58.2M+5.6% | $55.1M+33.5% | $41.3M+28.3% | $32.2M-7.3% | $34.7M |
| Gross profit | $146.3M+33.6% | $109.5M+2.4% | $107.0M+0.4% | $106.6M+24.8% | $85.4M+62.7% | $52.5M-4.3% | $54.9M |
| Sales, general and administrative | $165.1M+18.1% | $139.8M-4.0% | $145.6M+15.6% | $126.0M+36.6% | $92.2M+38.4% | $66.6M-5.9% | $70.8M |
| Research and development | $20.2M+2.7% | $19.7M-25.4% | $26.4M+30.4% | $20.3M+10.7% | $18.3M+32.8% | $13.8M-8.0% | $15.0M |
| Total operating expenses | $185.3M+16.2% | $159.5M-7.3% | $172.0M+17.6% | $146.3M+32.3% | $110.5M+37.5% | $80.4M-6.3% | $85.8M |
| Loss from operations | -$39.0M+22.0% | -$50.0M+23.1% | -$65.0M-64.0% | -$39.7M-57.7% | -$25.1M+9.9% | -$27.9M+9.8% | -$30.9M |
| Interest income | $423K-71.4% | $1.5M+44.8% | $1.0M+1072.4% | $87K+278.3% | $23K+53.3% | $15K+275.0% | $4K |
| Interest expense | -$25.3M-21.3% | -$20.8M-35.3% | -$15.4M-30.9% | -$11.8M-29.8% | -$9.1M+3.3% | -$9.4M-7.8% | -$8.7M |
| Other income (expense), net | $5.8M+138.1% | -$15.3M-1973.7% | $816K+125.7% | -$3.2M+49.3% | -$6.3M-134.0% | -$2.7M-122.3% | -$1.2M |
| Loss before income taxes | -$58.0M+31.4% | -$84.6M-7.7% | -$78.6M-7.9% | -$72.8M-83.4% | -$39.7M-4.5% | -$38.0M-1.4% | -$37.5M |
| Benefit (provision) for income taxes | $7.0M+21643.8% | $32K-60.5% | $81K+103.4% | -$2.4M-67.1% | -$1.4M-1272.1% | -$104K+83.8% | -$640K |
| Net loss | -$51.1M+39.6% | -$84.6M-7.8% | -$78.5M-4.4% | -$75.2M-82.8% | -$41.1M-7.9% | -$38.1M+0.1% | -$38.1M |
| Basic net loss per share (in dollars per share) | -$2K+42.7% | -$3K+2.3% | -$3K+0.3% | -$3K-79.1% | -$2K-5.5% | -$2K+12.4% | -$2K |
| Diluted net loss per share (in dollars per share) | -$2K+42.7% | -$3K+2.3% | -$3K+0.3% | -$3K-79.1% | -$2K-5.5% | -$2K+12.4% | -$2K |
| Weighted average outstanding shares used for basic net loss per share (in shares) | $29.62B+5.2% | $28.16B+10.0% | $25.60B+4.7% | $24.46B+2.0% | $23.97B+2.8% | $23.32B+13.5% | $20.54B |
| Weighted average outstanding shares used for diluted net loss per share (in shares) | $29.62B+5.2% | $28.16B+10.0% | $25.60B+4.7% | $24.46B+2.0% | $23.97B+2.8% | $23.32B+13.5% | $20.54B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.